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Abstract 
Guided bone regeneration (GBR) has been utilized for several decades for the healing of 
cranio-maxillofacial bone defects and particular in the dental field by creating space with a 
barrier membrane to exclude soft tissue and encourage bone growth in the membrane 
protected volume. Although the first membranes were non-resorbable, a new generation of 
GBR membranes aims to biodegrade and provide bioactivity for better overall results. The 
Inion GTR™ poly(lactide-co-glycolide) (PLGA) membrane is not only resorbable, but also 
bioactive, since it includes N-methylpyrrolidone, which has been shown to promote bone 
regeneration. In this study, the effects of loading different amounts of NMP onto the 
membrane through chemical vapor deposition or dipping have been explored. In vitro 
release demonstrated that lower levels of NMP led to lower NMP concentrations and 
slower release based on total NMP loaded in the membrane. The dipped membrane 
released almost all of the NMP within 15 minutes, leading to a high NMP concentration. 
For the in vivo studies in rabbits, 6 mm calvarial defects were created and left untreated or 
covered with an ePTFE membrane or PLGA membranes dipped or preloaded with NMP. 
Evaluation of the bony regeneration revealed that the barrier membranes improved bony 
healing and that a decrease in NMP content improved the performance. Overall, we have 
demonstrated the potential of these PLGA membranes with a more favorable NMP release 
profile and the significance of exploring the effect of NMP on these PLGA membranes with 
regards to bone ingrowth. 
 
1. Introduction 
The concept of guided bone regeneration (GBR), which was developed into a therapy 
beginning in the 1980s (Nyman, Lindhe et al. 1982, Dahlin, Linde et al. 1988), is based on 
the formation of space to allow bone ingrowth while excluding soft tissues from entering 
the created compartment. The slower-growing osteoprogenitor cells can proliferate without 
competing with the undesired connective tissue. GBR greatly aids the formation of new 
bone in oral and maxillofacial tissues, which can present complications due to unusual 
geometries, necessity of precise application, and oral bacterial flora (Mikos, Herring et al. 
2006). GBR has contributed to closing bone gaps due to loss from trauma, periodontitis, or 
tumor resection that are non-self-healing and require an intervention. Formerly, the only 
viable option was utilizing autologous bone, which is effective, but requires harvesting 
bone from another site, a procedure often associated with pain and morbidity of the graft 
harboring site (McAllister and Haghighat 2007, Hughes, Ghuman et al. 2010). 
 
To apply this therapy, the GBR occlusive pocket is normally achieved by the placement of 
a membrane to physically seal off the area from non-bony tissue. The first generation of 
GBR membranes consisted of expanded polytetrafluorothylene (ePTF), a non-resorbable 
material (Dahlin, Linde et al. 1988, Retzepi and Donos 2010). This treatment, with the 
polymer’s stability and non-immunogenicity, produced reliable results and has long been 
held as the gold standard treatment (Hammerle and Jung 2003, Retzepi and Donos 2010). 
However, the risk of disturbing healing with the necessary second surgery to remove the 
permanent ePTF membrane is a significant drawback. A second generation of resorbable 
membranes was developed to address this issue. Additionally, degradable membranes 
can potentially provide better healing as the material resorption and bone ingrowth occur 
simultaneously. Both synthetic polymers, including polyesters (poly(lactic acid), 
poly(glycolic acid), and poly(caprolactone) and their copolymers) (Milella, Barra et al. 
2001, Geurs, Korostoff et al. 2008, Sculean, Nikolidakis et al. 2008, Gentile, Chiono et al. 
2011) and poly(ethylene glycol) (Wechsler, Fehr et al. 2008, Ramel, Wismeijer et al. 
2012), and biologically-derived materials, namely collagen (Colangelo, Piattelli et al. 1993, 
Parodi, Carusi et al. 1998, Wang and Carroll 2001, Tal, Kozlovsky et al. 2008, Coic, Placet 
et al. 2010), are the most common GBR membranes.  
 
Although these bioresorbable GBR membranes have shown some success and obviate 
the need for a second surgery, on their own they generally do not actively accelerate bone 
regeneration. As a third generation of GBR membranes, researchers have strived to 
develop biodegradable, occlusive materials that are also bioactive. The Inion GTR™ 
membrane is composed of biodegradable co-polymers of polylactic acid (PLA), 
polyglycolic acid (PGA) and trimethylene carbonate (TMC) and is temporarily softened with 
N-methyl pyrrolidone (NMP), enabling easy handling and placement (Pirhonen, Pohjonen 
et al. 2006). Moreover, our lab previously discovered that NMP is a substance capable of 
accelerating bone formation by enhancing the effect of bone morphogenetic protein-2 
(BMP-2) on osteoblasts (Miguel, Ghayor et al. 2009) and inhibiting bone resorption by 
suppressing osteoclast maturation and activity (Ghayor, Correro et al. 2011). 
Consequently, NMP must be considered not only as a plasticizer, but also as a drug, 
rendering the NMP-softened PLGA-based membrane the first GBR membrane that is 
occlusive, bioresorbable, and bioactive.  
 
The NMP treated PLGA membrane obtains its bioactivity though uncomplicated means, 
without the use of growth factors or other bioactive molecules that must maintain a proper 
protein structure to be effective. This simplicity can lead to a more reliable GBR 
membrane. Moreover, NMP is FDA-approved as an excipient in pharmaceutical 
formulations, inexpensive, and readily available. Its timed and sustained delivery, however, 
is difficult due to the small size of the molecule and its amphiphilic character. In order to 
optimize the bioactivity of NMP, the concentration and release profile of NMP that is 
optimal for bone regeneration has to be defined. For that purpose, three different 
concentrations of NMP were preloaded into the PLGA membrane with chemical vapor 
deposition and compared to the membrane dipped into liquid NMP and the gold standard 
of a GBR membrane, the ePTF membrane produced by Gore, in in vitro release studies 
and in a rabbit cranial defect model. This study demonstrates the significance of varying 
the NMP loading in PLGA membranes on NMP release and in vivo bone regeneration.  
 
2. Materials and Methods 
2.1 Membranes: Inion GTR™ (Inion Oy, Tampere, Finland) named PLGA 50 and 
GoreTex ePTFE™ (Gore, Flagstaff, Arizona, USA) named ePTFE were used in these 
studies.  
2.2 NMP Loading of Inion Membranes: NMP was loaded onto the Inion GTR membrane 
with chemical vapor deposition to obtain 10, 15, and 20% NMP in the membrane, 
henceforth designated as PLGA 10, PLGA 15, and PLGA 20, respectively. Membranes 
were placed on top of a piece of filter over a petri dish with NMP in a desiccator. 
Deposition took place at room temperature and with the aid of a pump connected to the 
desiccator over a period of 1-2 days. Membranes were weighed before and after 
deposition to determine the percent loading. The 50% NMP loading was obtained by 
dipping the membrane in NMP for 20 seconds followed by air-drying for 15 minutes; these 
membranes are henceforth designated PLGA 50. The dipping was performed according to 
the recommendation of the manufacturer. 
2.3 NMP In Vitro Release: 20 mm x 15 mm rectangular membranes were placed in 50 mL 
of phosphate buffered saline, pH 7.4. Samples were held at 37°C and shook at 100 rpm. 
200 µL was removed at each timepoint up to 16 weeks and stored at 4°C for later analysis. 
NMP concentration was measured at 220 nm using 96 well plates coated to enable 
reading at UV wavelengths (Corning, Corning, NY, USA). Values were compared to a 
standard curve of known NMP concentrations. The concentration of released NMP was 
equated to the equivalent membrane area (two 7 mm diameter membranes) and defect 
volume (100 µL) used in the in vivo rabbit experiments.  
 2.4 Structural analysis. The structural analysis was performed both times for four test 
specimens derived from the same Inion GTR membrane by cutting it in 4 pieces; 1) 
untreated, 2) vapor loaded with 20% (w/w) NMP, 3) vapor loaded with 20% (w/w) NMP 
exposed to 50 mL of phosphate buffered saline, pH 7.4 for 1 h, 4) dip loaded membrane 
exposed to 50 mL of phosphate buffered saline, pH 7.4 for 1h. Prior to SEM analysis the 
samples exposed to phosphate buffered saline had to be dried overnight by lyophilization 
(Christ Alpha 2-4). Next, all membranes were fixed on metallic SEM holders with fast glue. 
Prior to SEM analysis, membranes were sputtered with Gold (SCD 030, Baltec, Balzers 
Lichtenstein). Parameters for sputtering leading to a gold layer of 10 nm on the samples 
were as follows. Distance of sample to gold target: 60mm, sputtering time: 90 seconds, 
and current: 45mA. Membranes were analyzed using a Zeiss Supra V50 scanning electron 
microscope (SEM) (Carl Zeiss, Oberkochen, Germany) at an acceleration voltage of 5kV. 
 
2.5 Animal model: The ethical approval of the local authorities (Veterinäramt Zurich, 
Switzerland) was obtained before the start of the experiments. 15 new Zeeland white 
rabbits were sedated by ketamin and further anesthetized by a Halothan-N2O inhalation 
method. The surgical area was clipped and prepared with iodine for aseptic surgery.  A 
linear incision was made from the nasal bone to the midsagital crest. The soft tissues were 
reflected and the periosteum was dissected from the site (occipital, frontal, and parietal 
bones). Four 6 mm craniotomy defects were created (two in the parietal and two in the 
frontal bone) with a 6 mm trephine in a dental hand piece. The surgical area was flushed 
with saline to remove bone debris. To avoid any dural perforation the defects marked half 
way through the bone by the trephine were finally made by a round burr creating a 6 mm 
defect. Since the defect size was exactly 6 mm membranes on the dural side were chosen 
to be 7 mm in diameter and fixed by the pressure from the dura. Another rectangular 
membrane of 10x10mm was placed above the defect. This experimental scenario with 
membranes on both sides of the cranium has been developed by Linde and coworkers 
(Dahlin, Alberius et al. 1991). To determine the effect of released NMP on an empty 
defect, each defect in the parietal bone treated with a membrane was paired with a 
corresponding empty defect in the other parietal bone. The same was done for the frontal 
bone. The pairs were assigned randomly to the animals. To stabilize their positioning the 
two membranes of the top were sutured together and the entire unit sutured to the 
remaining periost. The soft tissues were closed with sutures. After the operation, analgesia 
was provided by injection of Novalgin (50 mg/kg). Four weeks after operation the rabbits 
were sacrificed after sedation with barbiturates by an overdose of ketamin and the 
calvarial bone was excised. 
2.6 Radiography and histology. Specimens were radiographed using a dental 
radiography unit with ultra-speed dental films (Eastman Kodak Company, NY, USA). The 
radiographs were photographed, scanned and later used to localize the middle section of 
the defects. After radiography, the samples were first prepared with a sequential water 
substitution process that involved 48 h in 40% ethanol, 72 h in 70% ethanol (changed 
every 24 h), 72 h in 96% ethanol and finally 72 h in 100% ethanol.  Samples were placed 
in xylene for 72 h for defatting the recovered bone (changed every 24 h). Next, infiltration 
was performed by placing the samples in methyl methacrylate (MMA) for 72 h (Fluka 
64200) followed by three days in 100 ml MMA + 2 g di-benzoylperoxide (Fluka 38581, 
dehydrated in desiccator) at 4 oC.  Samples were embedded by placing them in 100 ml 
MMA + 3 g di-benzoylperoxide + 10 ml plastoid N or dibuthylphtalate (Merck 800 19.25) 
and allowing polymerization to occur at 37 oC in an airtight water bath. 4.5 µm sections 
were prepared from the middle of the defects and stained with Goldner Trichrome. Digital 
images were taken and processed with an image analysis program (Adobe Photoshop). 
 
2.7 Analysis of data: The digital image of the vertical section from the middle of the 
defect was taken with a scale (mm) in order to localize the defect margins, which were six 
mm apart. In combination with the calvarial bone thickness of the surrounding bone, the 
total area of the defect could be reconstructed. Using the Adobe Photoshop Elements 
program, the total pixel number of the defect area could be determined. The part of the 
total defect filled by bone was also determined and expressed by pixel number of the bony 
area. Percentage of bone healing was calculated as: Bony regeneration [%] = pixel 
number of the bone area X 100/total pixel number of defect.  
Defect bridging was determined in the middle section to compare the extent of bone 
coverage across the x-axis of the defect. First, the areas with bone tissue were projected 
onto the x-axis. Next, the stretches of the x-axis where bone formation had occurred at any 
level were summed up as described earlier (Kruse, Jung et al. 2011). Bone bridging is 
given in percentage of the defect width (6 mm) where bone formation has occurred. 
 
 
2.8 Statistical analysis: Mean values and standard deviations were calculated for the 
percentage of bone regeneration and bone bridging. The significance of differences was 
evaluated by the Kruskal-Wallis test followed by the Mann-Whitney test. The significance 
of differences between membrane treated and the corresponding untreated defect was 
determined by the Wilcoxon signed rank test. The limit for significance was set to <0.05. 
Statistical analysis was performed by using a statistical software package (IBM SPSS 
Statistics Version 21 for Windows). 
 
3. Results 
 
3.1 In Vitro NMP Release 
PLGA membranes either preloaded with NMP using chemical vapor deposition or dipped 
into liquid NMP were assessed for their in vitro release of NMP. As shown in Figure 1A, 
the method of dipping the PLGA membrane into NMP and then letting it dry, which results 
in approximately 50% loading, leads to almost immediate loss of all of the NMP. After four 
minutes, 81.7% was released and over 95% was released after just 15 minutes. Moreover, 
the concentration in the first hour of the equivalent membrane and defect size as used in 
the in vivo experiments reached 130 mM (Figure 1C). In contrast, the preloaded 
membranes released NMP at a much slower rate. The PLGA 10 and PLGA 15 have 
similar curves, releasing about 20% after 7 hours and 37% after 24 hours (Figure 1A). The 
membranes with 20% NMP released significantly more than the other two preloaded 
conditions, beginning at 90 minutes. After 7 and 24 hours, PLGA 20 released almost 57% 
and 73% of the NMP, respectively. In the time intervals 0-1 hour, 1-4 hours, 4-9 hours, and 
9-24 hours, the PLGA 10 and PLGA 15 never reached an equivalent concentration of 
more than 5 mM (Figure 1B). However, the PLGA 20 released NMP to accumulate a 
concentration of at least 8.7 mM and up to 14.4 mM during these time intervals. The 
release from the PLGA 20 samples was prolonged over 16 weeks. The NMP release has 
already started to level out after one day and has almost reached a plateau by one week 
with 83% released. Over the course of the 16 weeks, additional NMP is continually slowly 
deposited in the supernatant, with a cumulative release of 96.6% after 16 weeks. The 
amount of loading has a pronounced effect on the release curve and local concentration of 
NMP.  
3.2 Structure of the membranes 
The type of loading the membrane with NMP influences the structure of the membrane. 
SEM analysis revealed that vapor deposition to 20% (w/w) NMP (PLGA 20) increases the 
thickness of the membrane in average from 236 µm to 266 µm (Figure 2A, 2B). Upon 
exposure to phosphate buffered saline for 1h and lyophilization the membrane which 
underwent NMP loading via vapor deposition (PLGA 20) was in average 249 µm thick, the 
dip loaded membrane (PLGA 50) in average 298 µm (Figure 2C, 2D). This marked 
increase in thickness of the dip loaded membrane in comparison to the vapor loaded 
membrane after exposure to phosphate buffered saline and the release of the majority of 
NMP is due to an increased porosity of the outer layers of the dip loaded membrane 
(Figure 2C, 2D lower panel) which has been described earlier (Pirhonen, Pohjonen et al. 
2006). 
3.3 Rabbit in Vivo Studies 
During the operation of the rabbits, it was evident that the ease of handling of PLGA 
membranes decreased with the NMP amount. With lower amounts of NMP, the membrane 
was stiffer, interfering with ease of membrane placement. After operation, no adverse 
reaction to any of the membranes occurred. All the animals remained in good health.  
In Figure 3, examples of some histological sections from the middle of the defect are 
shown. Although not shown, the PLGA 50 histology appears similar to the other PLGA 
membranes. More bone in-growth occurred with the PLGA membranes than the ePTFE. 
The bone formed during the 4-week repair phase is more of a cancellous type of bone 
rather than cortical bone. A cellular interaction with the membrane was not observed nor 
was bone deposited onto the membrane. A fibrous capsule was detected surrounding all 
of the membranes (including PLGA 20, not shown to maximize size of the images), with its 
thickness ranging from approximately 10 to 100 µm (Figure 4). Capsule thickness and 
NMP content did not appear to correlate either positively or negatively.  
Evaluation of the level of bony regeneration of the defect revealed that the use of 
membranes (GBR) improved bony healing and that a decrease in NMP content improved 
the performance of the respective membrane (Figure 5). All of the defects treated with 
membranes showed significantly more bone growth than their corresponding untreated 
controls except the PLGA 50. Both the PLGA 10 and PLGA 15 demonstrated significantly 
higher bony regeneration, both with an average of approximately 65%, than the ePTFE 
membrane. The determination of bone repair via pixel number is focused on the area with 
bone structures and, as is illustrated in Figures 3 and 4, the structure of the newly formed 
bone is more cancellous and encloses a lot of area not filled with solid bone. The results in 
empty defect controls located adjacent to NMP releasing membranes indicate that NMP 
spill over did not occur or alone without the GBR membrane did not improve bone 
regeneration.      
The defect bridging, which evaluates the bone projected onto the x-axis, also was 
significantly increased for the defects treated with a membrane compared to the untreated 
defects, excluding the PLGA 10 and ePTFE (Figure 6). The PLGA 10 facilitated 
significantly greater bone bridging than the ePTFE membrane and the other preloaded 
PLGA membranes indicate a higher level of defect bridging, although not significantly. 
Similar to the bony regeneration data, the empty defect controls did not show an effect of 
NMP alone on defect bridging.  
 
4. Discussion 
 
Calvarial models are the most selective models for bone regeneration because the poor 
blood supply and the membranous (cortical) structure of the bone have an adverse effect 
on bone healing (Schmitz and Hollinger 1986). In this project, no attempt was made to 
produce a critical size defect that by definition would not heal during the lifetime of an 
animal and its healing would require osteoinductive agents, like bone morphogenetic 
proteins (BMPs). Therefore, four single 6 mm in diameter defects instead of one 15 mm in 
diameter critical size defect per animal were created. The latter one would put the focus on 
the mechanical properties of the membrane needed to stretch the 15 mm or would 
demand for the use of bone substitute materials creating additional variables in this model. 
The size of the defect with 6 mm was selected to resemble the typical magnitude of an 
osteotomy gap in maxillofacial surgery and defects in dentistry. This strategy provides the 
possibility to evaluate the interaction between spontaneous bone regeneration and the 
influence of different GBR membranes on the healing response, including the influence of 
release profiles of bioactive substances from membranes.  
The overall results of this rabbit cranial defect study demonstrate that GBR is very 
effective in promoting the bony healing of such defects. Although ePTFE is non-
degradable, this membrane was used as a control because it is the original gold standard 
membrane for guided bone regeneration, its reliability, synthetic nature, and purity. The 
use of a degradable collagen based membrane as control would have shifted the focus of 
our study on NMP release to differences in mechanical properties and would demand for 
the use of a bone substitute material. The clinical drawbacks from needing to remove the 
ePTFE membrane are inconsequential in this study due to the time frame of the 
experiment. Compared to the gold standard ePTFE from Gore, all PLGA-based 
membranes performed at least equally well, if not better, depending on the analysis type. 
Moreover, in a clinical setting, the non-degradable ePTFE membrane necessitates an 
additional surgery to remove it, while the PLGA membranes will resorb. Although the 
PLGA membranes overall result in greater bone formation, it is evident that the NMP 
loading on the PLGA membrane influences its performance. The PLGA 10 and 15 
demonstrated significantly more bony regeneration than the ePTFE (Figure 5). 
Additionally, the PLGA 10 achieved significantly better defect bridging (Figure 6). From 
these results, it appears that the lower NMP loading linked with a slower NMP release 
produces greater bone regeneration. Although the lower NMP loading leads to greater 
regeneration, it is not entirely possible to determine if the loading method and the 
respective NMP release profile or the amount of NMP leads to differences.  
As clearly demonstrated with the in vitro results (Figure 1), the NMP release profile from 
the PLGA membranes varies based on the loaded amount and the loading methodology: 
dipping or vapor depositioning. The vapor deposited membranes retain NMP to a much 
greater extent than the dip-loaded membrane. As demonstrated with the long term data of 
PLGA 20, a majority of the NMP is released over the course of a week whereas the dip-
loaded membrane loses all NMP within minutes. This result is most likely due to the fact 
that the majority of NMP remains in the outer layer of the membrane with dipping, since 
NMP is only allowed 15 minutes to diffuse into the PLGA. Vapor deposition, however, 
allows the NMP time to diffuse throughout the membrane, since loading occurs over a time 
period of 1-2 days. The PLGA 20, which has the highest amount of NMP loaded with 
chemical vapor deposition, releases a significantly higher percent of NMP than the PLGA 
10 and 15 as well as has a higher NMP concentration at every interval, although not 
always significantly.  The fast burst release of NMP from the dipped PLGA membrane, 
PLGA 50, leads to an extremely high concentration of 130 mM in the first hour, which is 
potentially toxic to cells. Our previous experience has indicated that C2C12 cells are not 
viable with NMP concentrations greater than 10 mM (data not shown). The vapor 
deposited membranes, PLGA 10, PLGA 15, and PLGA 20; all maintained NMP 
concentrations lower than 10 mM at all calculated time intervals except 1-4 hours for 
PLGA 20. Although the in vivo situation is greatly complicated, these data illustrate the 
possibility of damagingly high NMP levels with the PLGA 50. Despite the fact that NMP is 
safe and approved in humans as an excipient by the FDA, it can be locally toxic at high 
levels (Davies, Ajami et al. 2013, Pelaez-Vargas, Gallego-Perez et al. 2013). Moreover, a 
longer release period, as in the case with the vapor deposited membranes and particularly 
PLGA 10 and 15, may promote NMP’s BMP-enhancing effects over an extended time 
period, possibly inducing greater bone growth. It is possible that both of these factors 
contributed to the improvement with lower NMP loading. The mechanical properties of the 
NMP membrane also change with the loading and release of NMP, which could contribute 
to differences in bone regeneration. However, the 6 mm cranial defect model is not 
sensitive to differences in the mechanical properties, as long as they are sufficient stiff so 
that a properly fixed membrane covers the defect without collapsing. Therefore we believe 
that differences in bone regeneration are mainly due to differences in the release kinetic of 
NMP which was shown in previous work to have bone enhancing effects (Miguel, Ghayor 
et al. 2009). 
Although the membranes with the lowest amount of NMP performed best, there are 
practical considerations that are important in a clinical setting that could favor other 
membrane formulations. From the handling characteristics, only the preloaded PLGA 20 is 
suitable for GBR in dentistry. When the NMP content is below 20%, the membrane is too 
stiff for this application. As mentioned previously, reducing NMP content below 20% led to 
better results. In order to develop a second generation of the PLGA membrane, we have 
to balance the NMP effect as a plasticizer and the pharmaceutical effect of NMP, which is 
lethal to cells at higher concentrations.  
Another aspect that should not be overlooked is that with the use of a preloaded 
membrane we lose the capability of tissue integration (Fig. 4). As previously demonstrated, 
the PLGA membranes that are dipped into NMP integrate with the tissue, with extensive 
ingrowth of cells and osteoid and new bone formation adjacent to the membrane 
(Pirhonen, Pohjonen et al. 2006). It is suspected that the surface roughness plays a crucial 
role in tissue integration (Figure 2). Before being placed in NMP, the polymer surface is 
dense with a smooth surface, but it obtains a three-part structure with a dense inner layer 
and outer rough porous layers upon dipping in NMP (Pirhonen, Pohjonen et al. 2006). It 
was previously shown that this smooth PLA/PGA/TMC film does not allow tissue 
integration into the membrane, while the roughened surface does promote incorporation. 
Simion et al. have shown that titanium-coated ePTFE membranes with high surface 
roughness integrated into the host tissue to a much greater extent in a GBR model 
(Simion, Dahlin et al. 1999). Additionally, other studies have described the positive 
relationship between surface roughness and osseointegration (Hayes and Richards 2010, 
Choong, Yuan et al. 2012, Davies, Ajami et al. 2013, Pelaez-Vargas, Gallego-Perez et al. 
2013). This topography mimics the natural bone remodeling situation where active 
osteoclasts create carved out pits and lacunae. Therefore, the membrane surface needs to 
be roughened prior to loading with NMP. If the roughening leads to an increased flexibility 
of the membrane, the NMP content could also be reduced and optimized for its 
pharmaceutical action. Moreover, since the PLGA membranes are resorbable, long-term 
cell integration of the membrane may not be important for the clinical outcome. 
Another cellular response that may not have long term consequences is the formation of a 
fibrous capsule that was found with all of the membranes (Figure 4). Since the PLGA 
membranes degrade, the fibrous capsule may break down once the material is no longer 
present, imparting no extended negative effects.  
 
5. Conclusion 
PLGA membranes loaded with various amounts of NMP all demonstrated bone 
regeneration that is equal to or better than the gold standard ePTFE membrane in a rabbit 
calvarial defect model. By utilizing vapor deposition for loading, we developed a slow NMP 
release system from PLGA. Differences between the PLGA membranes with different 
NMP loading were detected in the in vivo bone regeneration as well as in vitro NMP 
release profiles. The release curve of NMP may influence its performance. These results 
indicate the importance of analyzing and optimizing NMP release. Overall, we have 
demonstrated the potential of these PLGA membranes and the significance of exploring 
the effect of NMP on these PLGA membranes with regards to bone ingrowth.  
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Figure Captions 
Figure 1: In Vitro NMP Release. A) Cumulative percent release of NMP form PLGA 10, PLGA 15, PLGA 20, and PLGA 50 
membranes over 7 hours.  B) Calculated NMP concentration in the calvarial bone defect between 0‐1 hour, 1‐4 hours, 
4‐9 hours, and 9‐24 hours for PLGA 10, PLGA 15, PLGA 20, and PLGA 50. Fading indicates that the PLGA 50 data point 
at 0‐1 hour extends past the y‐axis. C) Calculated NMP concentration  in the calvarial bone defect between 0‐1 hour 
for PLGA 10, PLGA 15, PLGA 20, and PLGA 50  
 
 
Figure 2: Scanning electron microscope images of the Inion GTR membrane at lower and higher magnification. A) 
Inion GTR membrane, B) PLGA 20; C) PLGA 20 (vapor deposition) exposed to phosphate buffered saline and 
lyophilized, D) PLGA 50 (dip loading) exposed to phosphate buffered saline and lyophilized. In the upper panel the 
white bars represent 20 µm; in the lower panel 1 µm. 
 
 
Figure 3: Trichrome stained histological sections of defects created in rabbit calvarial bone. M indicates the 
membrane and the solid black line marks the length of the defect. Trichrome staining stains bone green and osteoid 
red. No encapsulation of the membrane was seen. Ingrowth of cells did not occur. A) PLGA 10 B) PLGA 15 C) PLGA 20 
D) ePTFE 
 
Figure 4: Interaction between different membranes and bone. A) PLGA 10 B) PLGA 15 C) PLGA 50 D) ePTFE. M 
indicates the membrane. Trichrome staining stains bone green and osteoid red. All membranes were surrounded by 
fibrous tissue of a thickness between 10 µm and 100 µm. Ingrowth of cells or a direct deposition of bone onto the 
membranes did not occur. The red bar indicates 200 µm. 
 
 
 
Figure 5: Bony regeneration of the defect.  The bony regeneration of the defect was determined based on percentage 
of pixel number A) Defects treated with membranes and B) the corresponding untreated defects. Compared to the 
ePTFE membrane, bone regeneration was significantly increased in defects treated with PLGA 10 or 15 NMP. P values 
are  provided.  The  difference  between membrane  treated  and  corresponding  empty  defect was  significant  for  all 
conditions except the PLGA 50 pairs. 
 
 
Figure 6: Defect bridging. Defect bridging as the percentage of the 6 mm defect bridged by bone in A) samples treated 
with membranes and B)  the  corresponding empty defects. Compared  to  the ePTFE membrane, bone bridging was 
significantly  increased  in  defects  treated with  PLGA  10.    P  value  is  provided.  The  difference  between membrane 
treated and corresponding empty defect was significant for PLGA 15, 20 and 50.  
 
 
